Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Fibrosis, Liver: early-phase trial registry
2 of 8 indexed Fibrosis, Liver trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Fibrosis, Liver: 8 US clinical trials tracked, 2 recruiting.
Fibrosis, Liver is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Pinnacle Clinical Research, P, running 1 of these trials.
Enrollment posture brief
Registry condition fibrosis-liver
OPEN 2 | RECR 25% | LATE 1 | EARLY 3 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)
Fibrosis, Liver lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Fibrosis, Liver on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Fibrosis, Liver is recruiting below its size-band peers.
2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Fibrosis, Liver trials is spread across many organizations.
Pinnacle Clinical Research, P accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Fibrosis, Liver enrolment sits around 300 participants.
Median target enrolment is 300 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
Fibrosis, Liver splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Endoscopic Ultrasound Shear Wave Elastography Study
Olympus Corporation of the Americas
NCT06592820
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
Massachusetts General Hospital
NCT05692024
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Joslin Diabetes Center
NCT04595474
LITMUS Imaging Study
University of Oxford
NCT05479721
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
Hepion Pharmaceuticals
NCT05402371
Liver Cancer Prevention Randomized Control Trial
M.D. Anderson Cancer Center
NCT05196867
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00006164
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis
Pinnacle Clinical Research, P
NCT03656068
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Fibrosis, Liver records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Fibrosis, Liver trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Fibrosis, Liver page
8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Fibrosis, Liver trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pinnacle Clinical Research, P sponsors the most Fibrosis, Liver trials on record, review their full trial history before evaluating a specific study. See Pinnacle Clinical Research, P's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fibrosis, Liver condition card totals 8 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.